Advertisement

Topics

Hyperlipidemia: Management With PCSK9 Inhibitors

08:00 EDT 6 Sep 2018 | Medscape

This article reviews the mechanism of action of PCSK9 inhibitors, as well as their efficacy, safety, costs, and limitations. For which patients are they recommended?
Journal of the American Board of Family Medicine

Original Article: Hyperlipidemia: Management With PCSK9 Inhibitors

NEXT ARTICLE

More From BioPortfolio on "Hyperlipidemia: Management With PCSK9 Inhibitors"

Advertisement
Quick Search
Advertisement
Advertisement